HWM
KRTX

HighMark Wealth Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

HighMark Wealth Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-55
Closed -$17.4K – 621
2023
Q4 		$17.4K Hold
55
– – 0.01% 205
2023
Q3 		$9.3K Sell
55
-20
-27% -$3.76K 0.01% 262
2023
Q2 		$16.3K Hold
75
– – 0.01% 202
2023
Q1 		$13.6K Hold
75
– – 0.01% 250
2022
Q4 		$14.7K Hold
75
– – 0.01% 201
2022
Q3 		$17K Hold
75
– – 0.01% 187
2022
Q2 		$9K Hold
75
– – 0.01% 269
2022
Q1 		$10K Hold
75
– – 0.01% 273
2021
Q4 		$10K Sell
75
-130
-63% -$16.8K 0.01% 265
2021
Q3 		$25K Buy
205
+18
+10% +$2.08K 0.02% 166
2021
Q2 		$21K Buy
187
+17
+10% +$1.99K 0.02% 184
2021
Q1 		$20K Buy
+170
New +$19.3K 0.02% 171

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

HighMark Wealth Management's KRTX Position: Q1 2024 in Review

HighMark Wealth Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 55 shares — an estimated $17.4K sold.

HighMark Wealth Management first reported a position in KRTX in Q1 2021 and held it in 12 quarters. The position peaked at $25K in Q3 2021. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • HighMark Wealth Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • HighMark Wealth Management sold 55 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $17.4K.
  • HighMark Wealth Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • HighMark Wealth Management's Karuna Therapeutics, Inc. Common Stock position peaked at $25K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on HighMark Wealth Management's 13F filing for Q1 2024, filed 29 Apr 2024.